May 2019

Cardiologist agrees to $5.8M settlement for implanting dozens of unnecessary stents ()
Energy drink consumption triggers high BP, electrical abnormalities in heart ()
Survey: Nearly half of hypertensives unworried about future CV events ()
Proton pump inhibitors linked to fatal cases of CVD, CKD, stomach cancer ()
FDA fast-tracks new CV indication for Vascepa ()
Ultra-processed foods threaten CV health in Western countries ()
Fasting before cholesterol labs is futile, researchers say ()
COAPT: Patients with HF, mitral regurgitation see better health outcomes with TMVR ()
Heart attack victims wait an average of 3 hours to get help—here’s why ()
AFib market expected to reach $14.7B by 2026 ()
Some e-cig flavors could be more toxic than others ()
Millennials less heart-healthy than Gen Xers at the same age ()
Some Canadians waiting more than a year for elective echos ()
Fertility treatment linked to peripartum cardiomyopathy ()
Immigrant with heart failure, CAD deported without adequate access to healthcare ()
ACC names 1st-ever director of diversity and inclusion ()
Veterans with PTSD, depression more likely to participate in cardiac rehab ()
1st live transmission of robotic PCI performed in Europe ()
Women less likely to be resuscitated than men during OHCA ()
Andrea Russo inducted as HRS president ()
Study suggests MRI should be standard practice for NSTEMI diagnosis, treatment ()
More than ⅔ of cardiovascular RCT reports skew language to reflect better outcomes ()
Orsiro achieves lower target lesion failure, revascularization than thicker stents ()
New guidelines redefine cardiogenic shock ()
Abiomed’s Impella RP system is safe, FDA says ()
Antibacterial envelope cuts risk of CIED infection by 40% ()
How to alleviate patient anxiety about ICDs ()
Abbott’s tricuspid valve repair system finds success in TRILUMINATE study ()
Algorithm optimizes catheter ablation in AFib patients ()
Dabigatran no more effective than aspirin for recurrent stroke prevention ()
For teens, being overweight is just as risky as being obese ()
Grapefruit juice prolongs patients’ QT interval ()
Myocardial injury commonly miscoded as type 2 MI ()
Early gastric bypass improves odds of diabetes remission in teens ()
T-cells in arterial plaque could signal stroke risk ()
FDA approves 1st anticoagulant for use in pediatric patients ()
ICDs are underused in clinical practice—especially in women and minorities ()
More than ⅓ of statin patients fail to achieve healthy LDL-C ()
First personal 6-lead ECG cleared for sale in US ()
Arthritic pain reliever glucosamine cuts risk of CVD death by 22% ()
Federal judge: Illegal actions by FDA fueled e-cig epidemic ()
New rule allows physicians to refuse care on grounds of religious, moral beliefs ()
Azithromycin ‘Z-packs’ tied to potentially fatal arrhythmia ()
Generic equivalent of Pfizer hypertension drug approved ()
Risk of low-dose aspirin outweighs benefit in general population ()
How AI could prevent unnecessary testing in patients with chest pain ()
CV deaths in the UK trending up for 1st time in 50 years ()
HRS releases consensus statement on arrhythmogenic cardiomyopathy: 5 things to know ()
Algorithm tops physicians in predicting heart attacks, death ()
Bioengineered blood vessels could replace vasculature damaged by renal failure, CVD ()
Researchers developing AI-powered ‘smart ring’ to detect AFib ()
How cardiologists reacted to the rapid rise and fall of BVS ()
Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia ()
The Opioid Crisis May Be Coming to Your Cardiology Practice ()
Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It Alone ()
From Concept to Clearance: Why It’s So Expensive to Develop New CV Drugs ()
Going the Distance: Is Telestenting a New Path for PCI? ()
‘Really Not Close’: TAVR Trumps SAVR in Two Trials of Low-risk Patients ()
Positive Projections: TAVR/TMVR Market Likely to Double by 2023 ()
Making the Case for Cardiac PET: Before Buying in, Evaluate Clinical & Business Considerations ()
BioCardia receives clearance for AVANCE steerable catheter introducers ()
Study reveals patients don’t know much about their heart implants—but they want to ()
Antiglycemic agent tied to 55 cases of life-threatening gangrene in diabetics ()
More young people in the US are dying from HF-related CVD ()
CVD in pregnancy the leading cause of death among US mothers ()
Diabetic ketoacidosis more widespread in the US than Canada ()
UGA researchers find 27 new metabolites tied to arterial stiffness ()
FDA: Certain Medtronic pacemaker, CRT-P batteries can fail without warning ()
CRT vs. RV pacing: Which is better for HFpEF patients? ()
Preemie heart damage could be reversed with exercise in young adulthood ()
Arsenic in drinking water linked to LV thickening, hypertrophy ()
Biotech startup aims to eradicate CAD with gene editing ()
FDA OKs Pfizer’s tafamidis to treat cardiac amyloidosis ()
Migraine drug shows no increase in CV outcomes ()
ARB update: Vivimed issues 19-lot recall of losartan ()
Weighing the plausibility of a genetic test for predicting obesity ()
Prolonged exposure to low-dose radiation elevates risk of hypertension ()
Unnecessary procedures cost Kentucky cardiologist $1M, 5 years in prison ()
Oral infections during childhood linked to CVD later in life ()
CABG trumps PCI in multivessel CAD patients ()
Live in Las Vegas: SCAI.19 Expands Focus on Live Cases ()
AFib gadget packs BP monitor, ECG into singular device ()
STEMI DTU trial greenlighted by the FDA ()
AHA backs federal efforts to raise tobacco sale age to 21 ()
Sex-specific VIRGO taxonomy better classifies women with MI ()
Physicians often overlook statin guidelines for ASCVD patients ()
Losartan recall grows by another 35 lots ()
FDA clears world’s 1st active-fixation left heart lead ()
Viagra-like sex drug also effective as HF therapy ()